Institutional
FCPM III SERVICES B.V.
CIK 0002013410
$722.2M
Reported AUM
10
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · FCPM III SERVICES B.V. · Q1 2026
AI · grounded in 13F
FCPM III SERVICES B.V. established a new position in DMRA valued at $63.2M. The fund closed its entire position in RAPT, reducing exposure by $62.1M. Additionally, the fund increased its holdings in VOR by 13.8% and trimmed its stake in DYN by 15%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $294.5M | 40.77% | — | HELD |
| 2 | DYN | DYNE THERAPEUTICS INC | $84.2M | 11.66% | -818,460 | -15.0% |
| 3 | VOR | VOR BIOPHARMA INC | $73.5M | 10.17% | +500,000 | +13.8% |
| 4 | — | ENGENE HOLDINGS INC | $65.6M | 9.08% | — | HELD |
| 5 | MPLT | MAPLIGHT THERAPEUTICS INC | $65.6M | 9.08% | — | HELD |
| 6 | DMRA | DAMORA THERAPEUTICS INC | $63.2M | 8.75% | +2,441,000 | NEW |
| 7 | CBIO | CRESCENT BIOPHARMA INC. | $30.8M | 4.27% | — | HELD |
| 8 | REPL | REPLIMUNE GROUP INC | $21.5M | 2.97% | — | HELD |
| 9 | BCYC | BICYCLE THERAPEUTICS PLC | $16.1M | 2.23% | — | HELD |
| 10 | — | ENGENE HOLDINGS INC | $7.3M | 1.01% | — | HELD |
| 11 | RAPT | RAPT THERAPEUTICS INC | — | — | -1,833,333 | EXITED |
Source: SEC EDGAR · accession 0001193125-26-225423. 13F discloses long positions only — shorts, foreign equities, and options are excluded.